Clean Science Q1 FY27 Share Price & Earnings Call Analysis

Financials of Clean Science

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Clean Science

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +217188181195228224238241264243245220249
Expenses +112112106108133129148142159143158147153
Operating Profit10576758795959098105100877296
OPM %48%40%41%44%42%42%38%41%40%41%36%33%38%
Other Income +131368141011512137103
Interest0000100000000
Depreciation10111111131618181719191921
Profit before tax1087969839589838510095756378
Tax %25%25%25%25%26%26%29%23%26%26%26%27%25%
Net Profit +81595263706659667470554658
EPS in Rs7.585.554.915.896.616.205.536.186.976.595.224.325.48

Financials of Clean Science

Profit & Loss

Annual income statement trend

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +241393419512685936791967957
Expenses +167257234253385533459579602
Operating Profit74137186260300403332388355
OPM %31%35%44%51%44%43%42%40%37%
Other Income +51111253030413933
Interest100001110
Depreciation81114172536466978
Profit before tax70137182267305396326357310
Tax %30%28%23%26%25%25%25%26%26%
Net Profit +4998140198228295244264230
EPS in Rs345.41689.841,051.6718.6821.5127.7822.9724.8821.61
Dividend Payout %12%15%2%134%15%18%22%24%19%

Financials of Clean Science

Balance Sheet

Capital structure and asset base

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital111111111111111
Reserves1862713415297589991,1931,4061,573
Borrowings +133002222
Other Liabilities +485385120156140191181197
Total Liabilities2363274306609251,1521,3961,6001,783
Fixed Assets +102127166186296460636715760
CWIP2435544205730118
Investments1875133232191353339381405
Other Assets +114121128187394318364474500
Total Assets2363274306609251,1521,3961,6001,783

Financials of Clean Science

Cash Flows

Operating, investing and financing cash movement

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +4585160193127279236214275
Cash from Investing Activity +-17-94-105-187-79-270-185-152-203
Cash from Financing Activity +-5-11-55-6-0-55-53-53-64
Net Cash Flow23-20-0049-45-2108
Free Cash Flow1346110109-1296107274
CFO/OP91%88%109%100%65%93%94%80%103%

Financials of Clean Science

Ratios

Working capital efficiency and return ratios

Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days605561538257767779
Inventory Days937998156143122163156157
Days Payable854810118016690139103118
Cash Conversion Cycle69875829598999129118
Working Capital Days60623332906886105242
ROCE %59%59%61%47%44%29%27%21%

Continue your research

What Clean Science's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Ch. (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilis. (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF